Skip to main content
. 2013 May 7;2(6):e24841. doi: 10.4161/onci.24841

graphic file with name onci-2-e24841-g1.jpg

Figure 1. Anti-NY-ESO-1 antibody titers in the course of this study. Titers are expressed as 1/dilution. Sample numbers indicate clinical visit in the course of treatment and vary from patient to patient. The minimum interval between sequential samples was one month. The maximum time interval between entry into the study and study completion was 16 mo.